Last Updated on October 21, 2024 by The Health Master
The launch in India of a new C-19 vaccine developed jointly by the Serum Institute of India (SII) and US-based biotech firm Novavax is likely to be delayed to September, said Adar Poonawalla, the CEO of Serum.
He had said in January that the vaccine, named Corovax, was expected to be launched by June.
Poonawalla said the trials of Corovax had kicked off in India, but did not say why the vaccine launch was delayed.
“It has been tested against African and UK variants of C19 and has an overall efficacy of 89%,” tweeted Poonawalla, “Hope to launch by September 2021!”
Poonawalla said earlier this month that a temporary US ban on exports of critical raw materials could limit the production of C-19 virus vaccines such as Novavax.
India said on Friday it would prioritise domestic C-19 inoculations amid rising C-19 virus case and had told international buyers of its decision.
Also read:
These 4 Pharma companies invest in ABCD Technologies
MoU for effective implementation of Pharmacovigilance system in India
Pharma exporters to submit reimbursement claims in 3 months
PCI introduces Industry training programme for Pharmacy Teachers
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
